Pfizer acquires 40% stake in Brazilian generics firm Teuto
This article was originally published in Scrip
Executive Summary
Pfizer says it is aiming to boost its presence in Brazil by acquiring a 40% stake in the local generics firm Teuto, in a deal worth an initial $240 million. Through the agreement, the two companies will develop and commercialise generic medicines, said Pfizer.